Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/28018| Title: | Why the renin-angiotensin-aldosterone system (RAAS) in critically ill patients can no longer be ignored. | Austin Authors: | Zarbock, Alexander;Chawla, Lakhmir;Bellomo, Rinaldo | Affiliation: | Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Albert-Schweitzer-Campus 1, Geb. A1, 48149, Munster, Germany Veterans Affairs Medical Center, San Diego, CA, USA Department of Critical Care, The University of Melbourne, Melbourne, Australia Department of Intensive Care, Royal Melbourne Hospital, Parkville, VIC, Australia Intensive Care Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia |
Issue Date: | 14-Nov-2021 | Date: | 2021 | Publication information: | Critical Care 2021; 25(1): 389 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/28018 | DOI: | 10.1186/s13054-021-03816-x | ORCID: | 0000-0002-6011-8049 | Journal: | Critical Care | PubMed URL: | 34775967 | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/34775967/ | Type: | Journal Article | Subjects: | renin-angiotensin-aldosterone |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.